Recent Advances in the Role of Yes-associated Protein in Dermatosis

Overview

Journal Skin Res Technol

Specialty Biomedical Engineering

Date 2023 Mar 28

PMID 36973973

Authors

Xiaorong Jia

Li He

Zhi Yang

Affiliations

Soon will be listed here.

Abstract

Background: Dermatosis is a general term for diseases of the skin and skin appendages including scleroderma, psoriasis, bullous disease, atopic dermatitis, basal cell carcinoma, squamous cell carcinoma, and melanoma. These diseases affect millions of individuals globally and are a serious public health concern. However, the pathogenesis of skin diseases is not fully understood, and treatments are not optimal. Yes-associated protein (YAP) is a transcriptional coactivator that plays a role in the regulation of gene transcription and signal transduction.

Aims: To study the role of Yes-associated protein in skin diseases.

Materials And Methods: The present review summarizes recent advances in our understanding of the role of YAP in skin diseases, current treatments that target YAP, and potential avenues for novel therapies.

Results: Abnormal YAP expression has been implicated in occurrence and development of dermatosis. YAP regulates the cell homeostasis, proliferation, differentiation, apoptosis, angiopoiesis, and epithelial-to-mesenchymal transition, among other processes. As well as, it serves as a potential target in many biological processes for treating dermatosis.

Conclusions: The effects of YAP on the skin are complex and require multidimensional investigational approaches. YAP functions as an oncoprotein that can promote the occurrence and development of cancer, but there is currently limited information on the therapeutic potential of YAP inhibition for cancer treatment. Additional studies are also needed to clarify the role of YAP in the development and maturation of dermal fibroblasts; skin barrier function, homeostasis, aging, and melanin production; and dermatosis.

Citing Articles

YAP/TAZ Signalling Controls Epidermal Keratinocyte Fate.

Pankratova M, Riabinin A, Butova E, Selivanovskiy A, Morgun E, Ulianov S Int J Mol Sci. 2024; 25(23).

PMID: 39684613 PMC: 11641583. DOI: 10.3390/ijms252312903.

TAZ acting as a potential pathogenic biomarker to promote the development of lichen planus.

Wang N, Bai R, Cheng B, Luo R, He K, Du W Skin Res Technol. 2024; 30(2):e13597.

PMID: 38282282 PMC: 10823152. DOI: 10.1111/srt.13597.

The Pressurized Skin: A Review on the Pathological Effect of Mechanical Pressure on the Skin from the Cellular Perspective.

Chien W, Tsai T Int J Mol Sci. 2023; 24(20).

PMID: 37894888 PMC: 10607711. DOI: 10.3390/ijms242015207.

Hyaluronic acid-modified and verteporfin-loaded polylactic acid nanogels promote scarless wound healing by accelerating wound re-epithelialization and controlling scar formation.

Chen K, Liu Y, Liu X, Guo Y, Liu J, Ding J J Nanobiotechnology. 2023; 21(1):241.

PMID: 37496007 PMC: 10369727. DOI: 10.1186/s12951-023-02014-x.

Recent advances in the role of Yes-associated protein in dermatosis.

Jia X, He L, Yang Z Skin Res Technol. 2023; 29(3):e13285.

PMID: 36973973 PMC: 10155855. DOI: 10.1111/srt.13285.

References

Xiong H, Yu Q, Gong Y, Chen W, Tong Y, Wang Y . Yes-Associated Protein (YAP) Promotes Tumorigenesis in Melanoma Cells Through Stimulation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1). Sci Rep. 2017; 7(1):15528. PMC: 5686191. DOI: 10.1038/s41598-017-14764-4. View

Nan Y, Luo Q, Wu X, Liu S, Zhao P, Chang W . DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma. Cancer Res. 2022; 82(16):2887-2903. DOI: 10.1158/0008-5472.CAN-22-0717. View

Wang M, Dong Y, Gao S, Zhong Z, Cheng C, Qiang R . Hippo/YAP signaling pathway protects against neomycin-induced hair cell damage in the mouse cochlea. Cell Mol Life Sci. 2022; 79(2):79. PMC: 8770373. DOI: 10.1007/s00018-021-04029-9. View

Wang D, Lin L, Lei K, Zeng J, Luo J, Yin Y . Vitamin D3 analogue facilitates epithelial wound healing through promoting epithelial-mesenchymal transition via the Hippo pathway. J Dermatol Sci. 2020; 100(2):120-128. DOI: 10.1016/j.jdermsci.2020.08.015. View

Jia J, Mo X, Liu J, Yan F, Wang N, Lin Y . Mechanism of danshensu-induced inhibition of abnormal epidermal proliferation in psoriasis. Eur J Pharmacol. 2019; 868:172881. DOI: 10.1016/j.ejphar.2019.172881. View

Mermoud L, Shutova M, Diaz-Barreiro A, Talabot-Ayer D, Drukala J, Wolnicki M . IL-38 orchestrates proliferation and differentiation in human keratinocytes. Exp Dermatol. 2022; 31(11):1699-1711. PMC: 9796879. DOI: 10.1111/exd.14644. View

Jia J, Wang N, Zheng Y, Mo X, Zhang Y, Ye S . RAS-association domain family 1A regulates the abnormal cell proliferation in psoriasis via inhibition of Yes-associated protein. J Cell Mol Med. 2021; 25(11):5070-5081. PMC: 8178269. DOI: 10.1111/jcmm.16489. View

Azad T, Ghahremani M, Yang X . The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry. Cells. 2019; 8(5). PMC: 6562567. DOI: 10.3390/cells8050407. View

Jia J, Li C, Yang J, Wang X, Li R, Luo S . Yes-associated protein promotes the abnormal proliferation of psoriatic keratinocytes via an amphiregulin dependent pathway. Sci Rep. 2018; 8(1):14513. PMC: 6189173. DOI: 10.1038/s41598-018-32522-y. View

10.

Debaugnies M, Sanchez-Danes A, Rorive S, Raphael M, Liagre M, Parent M . YAP and TAZ are essential for basal and squamous cell carcinoma initiation. EMBO Rep. 2018; 19(7). PMC: 6030692. DOI: 10.15252/embr.201845809. View

11.

Yurchenko A, Pop O, Ighilahriz M, Padioleau I, Rajabi F, Sharpe H . Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma. Clin Cancer Res. 2022; 28(7):1422-1432. PMC: 9365352. DOI: 10.1158/1078-0432.CCR-21-3764. View

12.

Zhou K, Muroyama A, Underwood J, Leylek R, Ray S, Soderling S . Actin-related protein2/3 complex regulates tight junctions and terminal differentiation to promote epidermal barrier formation. Proc Natl Acad Sci U S A. 2013; 110(40):E3820-9. PMC: 3791730. DOI: 10.1073/pnas.1308419110. View

13.

Karvonen H, Barker H, Kaleva L, Niininen W, Ungureanu D . Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways. Cells. 2019; 8(8). PMC: 6721603. DOI: 10.3390/cells8080812. View

14.

Lee J, Jung Y, Jeong S, Jeong G, Moon G, Kim M . Inhibition of Hippo Signaling Improves Skin Lesions in a Rosacea-Like Mouse Model. Int J Mol Sci. 2021; 22(2). PMC: 7832320. DOI: 10.3390/ijms22020931. View

15.

Wu D, Wang W, Li X, Yin B, Ma Y . Single-cell sequencing reveals the antifibrotic effects of YAP/TAZ in systemic sclerosis. Int J Biochem Cell Biol. 2022; 149:106257. DOI: 10.1016/j.biocel.2022.106257. View

16.

Kim J, Kim Y, Kim J, Park D, Bae H, Lee D . YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation. J Clin Invest. 2017; 127(9):3441-3461. PMC: 5669570. DOI: 10.1172/JCI93825. View

17.

Martins Estevao B, Miletto I, Marchese L, Gianotti E . Optimized Rhodamine B labeled mesoporous silica nanoparticles as fluorescent scaffolds for the immobilization of photosensitizers: a theranostic platform for optical imaging and photodynamic therapy. Phys Chem Chem Phys. 2016; 18(13):9042-52. DOI: 10.1039/c6cp00906a. View

18.

Yap A, Duszyc K, Viasnoff V . Mechanosensing and Mechanotransduction at Cell-Cell Junctions. Cold Spring Harb Perspect Biol. 2017; 10(8). PMC: 6071489. DOI: 10.1101/cshperspect.a028761. View

19.

Gao Y, Luo C, Rui T, Fan Y, Yao Y, Shen H . Autophagy inhibition facilitates wound closure partially dependent on the YAP/IL-33 signaling in a mouse model of skin wound healing. FASEB J. 2021; 35(10):e21920. DOI: 10.1096/fj.202002623RRR. View

20.

Al-Busani H, Al-Sobaihi S, Nojima K, Tanemura A, Yaguchi T, Kawakami Y . NUAK2 localization in normal skin and its expression in a variety of skin tumors with YAP. J Dermatol Sci. 2020; 97(2):143-151. DOI: 10.1016/j.jdermsci.2020.01.008. View